157 related articles for article (PubMed ID: 3144532)
21. Renal tolerance of fleroxacin in healthy volunteers.
Mondorf AW; Buch A; Steinbacher G; Rüdel C; Falkenberg FW
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():179-89. PubMed ID: 2904925
[TBL] [Abstract][Full Text] [Related]
22. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers.
Naber KG; Theuretzbacher U; Kinzig M; Savov O; Sörgel F
Antimicrob Agents Chemother; 1998 Jul; 42(7):1659-65. PubMed ID: 9661000
[TBL] [Abstract][Full Text] [Related]
23. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
Weidekamm E; Portmann R; Suter K; Partos C; Dell D; Lücker PW
Antimicrob Agents Chemother; 1987 Dec; 31(12):1909-14. PubMed ID: 3125788
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
Panneton AC; Bergeron MG; LeBel M
Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338
[TBL] [Abstract][Full Text] [Related]
25. Bactericidal kinetics of various dosages of fleroxacin simulated in bacterial cultures.
Bauernfeind A; Eberlein E; Hörl G
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():81-9. PubMed ID: 3144553
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.
Nakashima M; Uematsu T; Kosuge K; Umemura K; Hakusui H; Tanaka M
Antimicrob Agents Chemother; 1995 Jan; 39(1):170-4. PubMed ID: 7695301
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.
Christenson JG; Chan KK; Cleeland R; Dix-Holzknecht B; Farrish HH; Patel IH; Specian A
Antimicrob Agents Chemother; 1990 Oct; 34(10):1895-900. PubMed ID: 2127171
[TBL] [Abstract][Full Text] [Related]
28. The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
Leibovitz E; Keren G; Shabtai M; Barzilai A; Rubinstein E
J Antimicrob Chemother; 1989 Sep; 24(3):375-85. PubMed ID: 2509411
[TBL] [Abstract][Full Text] [Related]
29. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
Hummler H; Richter WF; Hendrickx AG
Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
[TBL] [Abstract][Full Text] [Related]
30. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.
Gonzalez MA; Uribe F; Moisen SD; Fuster AP; Selen A; Welling PG; Painter B
Antimicrob Agents Chemother; 1984 Nov; 26(5):741-4. PubMed ID: 6517556
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis.
Pust RA; Ackenheil-Köppe HR; Weidner W; Meier-Ewert H
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():227-30. PubMed ID: 3144543
[TBL] [Abstract][Full Text] [Related]
32. Penetration of fleroxacin into breast milk and pharmacokinetics in lactating women.
Dan M; Weidekamm E; Sagiv R; Portmann R; Zakut H
Antimicrob Agents Chemother; 1993 Feb; 37(2):293-6. PubMed ID: 8452360
[TBL] [Abstract][Full Text] [Related]
33. Penetration of fleroxacin into maxillary sinus mucosa and palatine tonsil.
Baba S; Mori Y; Maruo T
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():195-7. PubMed ID: 3144538
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of fleroxacin in renal impairment.
Weidekamm E
Am J Med; 1993 Mar; 94(3A):70S-74S. PubMed ID: 8452185
[TBL] [Abstract][Full Text] [Related]
35. The penetration of fleroxacin into intra-abdominal abscesses.
Youngs DJ; Tudor RG; Yoshioka K; Keighley MR
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():115-8. PubMed ID: 3144528
[TBL] [Abstract][Full Text] [Related]
36. Quinolone pharmacokinetics and metabolism.
Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
[TBL] [Abstract][Full Text] [Related]
37. Penetration of ciprofloxacin and fleroxacin into biliary tract.
Edmiston CE; Suarez EC; Walker AP; Demeure MP; Frantzides CT; Schulte WJ; Wilson SD
Antimicrob Agents Chemother; 1996 Mar; 40(3):787-91. PubMed ID: 8851613
[TBL] [Abstract][Full Text] [Related]
38. Fleroxacin clinical pharmacokinetics.
Stuck AE; Kim DK; Frey FJ
Clin Pharmacokinet; 1992 Feb; 22(2):116-31. PubMed ID: 1551289
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone.
Weidekamm E; Stöckel K; Dell D
Chemioterapia; 1987 Jun; 6(2 Suppl):307-8. PubMed ID: 3151346
[No Abstract] [Full Text] [Related]
40. Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.
Wise R; Kirkpatrick B; Ashby J; Griggs DJ
Antimicrob Agents Chemother; 1987 Feb; 31(2):161-3. PubMed ID: 3105446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
